David Ewing Duncan is an award-winning, best-selling author of eight books published in 21 languages. He is a correspondent forThe Atlantic and the chief correspondent for NPR Talk’s Biotech Nation. David writes for The New York Times, Fortune, Wired, National Geographic, Discover and many other publications. He is a former commentator for NPR's Morning Edition and a special correspondent and producer for ABC’s Nightline. His latest book is When I'm 164: The new science of radical life extension, and what happens if it succeeds. He is the founding director of the Center of Life Science Policy at UC Berkeley. He is the Co-Founder and Curator of the Arc meetings and programs. David is finishing his first novel, a biomedical thriller. He lives in San Francisco. www.davidewingduncan.com.